Hypersensitivity (including to gentamicin sulfate, formaldehyde, merthiolate, sodium deoxycholate, chicken egg protein used in the technological process), acute infectious diseases or exacerbation of chronic diseases. For mild acute respiratory infections, acute intestinal diseases, etc., vaccinations are carried out immediately after the normalization of body temperature.
Hypersensitivity, including to the protein of chicken eggs, etc. the components of the vaccine in the anamnesis. Vaccination should be postponed for acute infectious diseases.
allergic reactions to previous vaccinations with influenza vaccines,
allergic reactions to chicken protein and vaccine components,
acute febrile conditions or exacerbation of a chronic disease,
the period of breastfeeding.
For parenteral administration: hypersensitivity, acute infectious and non-infectious diseases, chronic diseases in the acute stage, diffuse connective tissue diseases, adrenal diseases, hereditary and degenerative diseases of the nervous system, allergic diseases, with intranasal administration: hypersensitivity, chronic rhinitis, acute infectious and non-infectious diseases, exacerbation of chronic diseases. Age (up to 7 years).
Hypersensitivity (including to the protein of chicken eggs) or allergic reactions to a previous vaccination with this drug in the anamnesis. Vaccination should be postponed for acute infectious diseases.
The effectiveness of immunization may decrease against the background of immunosuppressive therapy or immunodeficiency.
Grippovac can be used simultaneously with other vaccines (in this case, the vaccines must be injected into different parts of the body with separate syringes).
The vaccine can be used simultaneously with other inactivated vaccines. At the same time, contraindications to each of the vaccines used should be taken into account, the drugs should be injected into different parts of the body with different syringes. Vaccination of patients receiving immunosuppressive therapy may be less effective.
Soreness, redness and swelling at the injection site, a slight and short-term increase in body temperature, fever, malaise (all these symptoms go away independently within 1-2 days).
Individuals with known sensitivity to certain components of the vaccine developed allergic reactions in the form of itching, urticaria, and rash. Severe allergic reactions such as anaphylactic shock were extremely rare.
Extremely rare: neuralgia, paresthesia, convulsions, transient thrombocytopenia, neurological disorders, vasculitis.
There may be allergic reactions, local reactions, malaise, headache, fever, sweating, myalgia, arthralgia, in very rare cases, as with any vaccination, it is possible to develop minor neurological complications.
The introduction of the vaccine may be accompanied by local and general reactions.
Very rarely-at the injection site, there may be reactions in the form of soreness, redness and swelling of the skin.
Extremely rare-in individuals, general reactions are possible in the form of increased fatigue, headache, dizziness, subfebrile fever, runny nose, pharyngitis, cough, arthralgia, myalgia, nausea. These reactions usually disappear on their own after 1-3 days.
In extremely rare cases — with high individual sensitivity, allergic reactions may occur.
With parenteral administration: fever, malaise, headache, hyperemia, swelling, very rarely-limited infiltrates, with intranasal-fever, malaise, headache.
There may be allergic, local reactions, malaise, headache, fever, sweating, myalgia, arthralgia, in very rare cases, as with any vaccination, it is possible to develop minor neurological complications.
children from 6 years old,
students of higher and secondary vocational educational institutions,
working adults, especially employees of medical and educational institutions, transport, and public utilities,
persons suffering from chronic somatic diseases,
persons who often suffer from acute respiratory diseases,
adults over 60 years old.
Influenza, post-influenza complications (prevention), relief of the disease in children over 7 years of age and adults.
Prevention of influenza in adults and children older than 6 months.
In/m or p/c (deep). Adults and children over 36 months — 0.5 ml once, children from 6 months to 35 months-0.25 ml once. Children who have not previously been vaccinated and have not had the flu should be re-administered the vaccine at an appropriate dose at intervals of at least 4 weeks. For the immunization of children who are shown the introduction of half the dose (0.25 ml), it is necessary to take half the contents of the ampoule or vial using a graduated syringe, which allows you to measure the specified volume. The remainder of the vaccine in the ampoule or vial must be destroyed.
Patients with thrombocytopenia and other diseases of the blood clotting system are administered only p/K.
V / m, n / a, shake before use. Children from 6 months to 3 years — 0.25 ml, from 3 years and adults-0.5 ml once, children under 3 years who were not vaccinated in previous years are recommended to be vaccinated twice in 0.25 ml with an interval of 4 weeks.
In/m, in the deltoid muscle.
The vaccine is administered once in a dose of 0.5 ml.
In case of mild acute respiratory infections, acute intestinal diseases, vaccination is carried out after the temperature is normalized. Vaccinations are carried out after recovery (remission).
On the day of vaccination, the vaccinated should be examined by a doctor / paramedic with mandatory thermometry. At temperatures above 37 °C, vaccination is not carried out.
The drug is not suitable for use in ampoules or syringes with impaired integrity or labeling, with a change in physical properties (color, transparency), with an expired expiration date, violation of the requirements for storage conditions.
Ampoules
Before use, the vaccine should be kept at room temperature and shaken well.
The opening of the ampoules and the vaccination procedure is carried out in strict compliance with the rules of asepsis and antiseptics: before opening the ampoule knife, the neck of the ampoule is wiped with cotton wool soaked in 70% ethyl alcohol, the ampoule is opened, the vaccine is collected in a single-use syringe and the remaining air is removed from the syringe. Alcohol is rubbed on the skin at the injection site. The drug in the opened ampoule is not subject to storage.
Syringes
You should shake the syringe immediately before the injection. Remove the protective cover from the needle and remove the air from the syringe by holding it in a vertical position with the needle up and slowly pressing the plunger.
N / a, once 0.5 ml in the area of the outer surface of the shoulder a few centimeters below the shoulder joint.
Intranasally, 0.5 ml (0.25 ml in each nasal passage) twice with an interval of 21-28 days (it is permissible to extend the interval by 1-2 weeks).
V / m, n / a, shake before use. Children from 6 months to 3 years — 0.25 ml, from 3 years and adults-0.5 ml once, children under 3 years who were not vaccinated in previous years are recommended to be vaccinated twice in 0.25 ml with an interval of 4 weeks.
